Skip to content

Why Most Confidentiality Agreements in Research Collaborations Backfire at the Worst Possible Moment

A. Kovacs A. Kovacs
/ / 4 min read

Confidentiality agreements in research collaborations get signed fast and read slowly. A company wants to share background IP with a university lab. The university wants to protect its researchers' ability to publish. Both sides want to look cooperative. So someone pulls a standard NDA template off a shared drive, a few people initial it, and everyone moves on to the science.

Focused close-up of an NDA document on a wooden desk, highlighting contract details. Photo by RDNE Stock project on Pexels.

Then, eighteen months later, something goes wrong.

Maybe the startup wants to file a patent and discovers its core claims were embedded in a slide deck shared during a kickoff meeting, technically disclosed under terms that muddy inventorship. Maybe the university researcher gave a conference talk that, in retrospect, described confidential technical details provided by the company partner. Maybe the company's own internal team built on the university's preliminary findings without anyone flagging that those findings were shared under a mutual agreement with publication restrictions attached.

None of these scenarios are exotic. They happen in productive collaborations, not failed ones.

The Template Problem

Most research NDAs are bilateral, mutual, and vague about scope. "Confidential Information" gets defined as anything marked confidential, or anything that a reasonable person would understand to be confidential, or both. That ambiguity feels safe at the drafting stage. Both sides feel protected. What it actually creates is a zone of uncertainty that nobody actively manages.

Researchers don't think in terms of what's marked confidential. They think in terms of what's interesting. Graduate students don't read NDAs. Postdocs don't read NDAs. The PI who signed the agreement may not have even kept a copy.

And here's the compounding issue: research collaborations generate information continuously, through lab meetings, shared data folders, Slack channels, informal calls. Tracking what was confidential when, and under which agreement, requires discipline that almost no academic lab has been set up to maintain.

Publication Rights Make Everything Harder

Universities will not sign away publication rights. Full stop. So almost every research NDA in an academic context includes a publication review window: typically 30 to 90 days during which the company can review manuscripts or presentations for confidential information and, in some cases, request patent filings before public disclosure.

That window sounds reasonable. In practice, it creates friction at exactly the wrong moment. A PhD student submitting their dissertation. A postdoc on the job market with one paper left to publish. A PI whose tenure case depends on a high-profile submission. The 60-day clock feels academic in the abstract and catastrophic in context.

Worse, the review window often gets ignored informally, then enforced formally when something goes sideways. The agreement was there the whole time. Nobody followed it. Now it's a problem.

graph TD
    A[Research Collaboration Begins] --> B(NDA Signed)
    B --> C{Information Shared}
    C --> D[Company Background IP]
    C --> E[University Preliminary Findings]
    D --> F(Publication Review Window Triggered)
    E --> F
    F --> G{Conflict Identified?}
    G --> H[Patent Filing or Redaction Required]
    G --> I[Publication Proceeds]

What a Better Agreement Actually Does

A well-constructed confidentiality agreement for a research collaboration does three things that most templates skip.

First, it distinguishes between background information and foreground information at the outset. Background is what each party brings in. Foreground is what gets generated during the collaboration. These categories need different treatment, and conflating them is where most disputes originate.

Second, it includes a residuals clause with teeth. Researchers will retain general knowledge and skills from any collaboration. A residuals clause acknowledges this explicitly rather than pretending researchers can selectively forget what they've learned. Companies that insist on overly broad confidentiality obligations in academic settings are setting themselves up for unenforceability anyway.

Third, it names specific people and processes for confidentiality management. Not "the parties shall" do something. Actual human beings, with actual responsibilities, for flagging incoming confidential information, tracking shared materials, and managing the publication review process. One person on each side. Named in the agreement.

None of this requires longer agreements. It requires more precise ones.

The Underlying Tension

Companies want certainty. Universities want freedom. A standard NDA tries to thread that needle by being vague enough that both sides can feel comfortable. The problem is that vagueness is a debt, not a solution. It gets paid later, with interest, when the collaboration produces something valuable enough to fight over.

Sign precise agreements early. Brief the research team on what they mean. Build in a process for managing confidential information as it flows, not just at signing. The science takes long enough. The legal cleanup shouldn't add another year to it.

Get Commercializing Science in your inbox

New posts delivered directly. No spam.

No spam. Unsubscribe anytime.

Related Reading